252004-45-8 Usage
Uses
Used in Pharmaceutical Industry:
4-CHLORO-2,6-DIFLUOROBENZALDEHYDE serves as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 4-CHLORO-2,6-DIFLUOROBENZALDEHYDE is utilized as an intermediate for the production of pesticides and other agrochemicals. Its incorporation into these products can enhance their effectiveness in protecting crops and managing pests.
Used in Organic Synthesis:
4-CHLORO-2,6-DIFLUOROBENZALDEHYDE is a valuable building block in organic synthesis, enabling the creation of a wide range of organic compounds for various applications, including specialty chemicals, materials science, and more.
Used in Research and Development:
Due to its potential anti-inflammatory and antioxidant properties, 4-CHLORO-2,6-DIFLUOROBENZALDEHYDE is used in research and development settings to explore its therapeutic potential and understand its mechanisms of action.
Check Digit Verification of cas no
The CAS Registry Mumber 252004-45-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,2,0,0 and 4 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 252004-45:
(8*2)+(7*5)+(6*2)+(5*0)+(4*0)+(3*4)+(2*4)+(1*5)=88
88 % 10 = 8
So 252004-45-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H3ClF2O/c8-4-1-6(9)5(3-11)7(10)2-4/h1-3H
252004-45-8Relevant academic research and scientific papers
SEROTONIN RECEPTOR MODULATORS
-
Page/Page column 140, (2010/07/10)
The biphenyic compounds of formula (I) are serotonin modulators useful in the treatment of serotonin-mediated diseases.
Isothiazole derivatives useful as anticancer agents
-
, (2008/06/13)
The present invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein X1, R1, R2and R3are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and to methods treating hyperproliferative disorders in mammals by administering the above compounds.
